IONIS PHARMACEUTICALS INC (IONS) Stock Analyst Earnings Estimates
NASDAQ:IONS - Nasdaq - US4622221004 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 810.5M 11.13% | 587.4M -27.53% | 787.647M 34.09% | 630.96M -19.89% | 692.73M 9.79% | 942.65M 36.08% | 1.367B 45.02% | 1.796B 31.38% | 2.374B 32.18% | 2.857B 20.35% | 3.434B 20.20% | 3.866B 12.58% | |
| EBITDA YoY % growth | 11.6M 109.18% | -393.5M -3,492.24% | -320.879M 18.46% | -521.249M -62.44% | -636.174M -22.05% | -401.629M 36.87% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -6.3M 95.56% | -410.2M -6,411.11% | -333.73M 18.64% | -544.345M -63.11% | -584.842M -7.44% | -411.757M 29.60% | -151.508M 63.20% | 140.52M 192.75% | 594.12M 322.80% | 988.02M 66.30% | 1.28B 29.55% | 1.635B 27.73% | |
| Operating Margin | -0.78% | -69.83% | -42.37% | -86.27% | -84.43% | -43.68% | -11.08% | 7.82% | 25.03% | 34.58% | 37.27% | 42.29% | |
| EPS YoY % growth | -0.38 -5.56% | -2.89 -660.53% | -2.56 11.42% | -3.55 -38.64% | -3.86 -8.80% | -2.83 26.79% | -0.76 73.08% | 1.42 286.86% | 4.00 181.21% | 5.93 48.28% | 6.57 10.80% | 8.00 21.74% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.15 -1,808.61% | -1.14 -15.83% | -1.05 -133.47% | -1.10 -16.11% | -0.91 20.13% |
| Revenue Q2Q % growth | 140.38M -56.81% | 148.91M 25.13% | 173.29M -23.07% | 169.1M 26.19% | 200.55M 42.86% |
| EBITDA Q2Q % growth | -159.248M -1,924.57% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -180.036M -4,266.62% | -166.748M -11.53% | -146.996M -122.41% | -160.855M -8.21% | -144.738M 19.61% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.95 7.77% | -1.18 | 0.23 | 19.50% |
| Q2 2024 Q2Q % growth | -0.45 25.00% | -0.94 | 0.49 | 52.10% |
| Q1 2024 Q2Q % growth | -0.98 -12.64% | -1.07 | 0.09 | 8.61% |
| Q4 2023 Q2Q % growth | -0.06 95.59% | -0.85 | 0.79 | 92.92% |
| Q3 2023 Q2Q % growth | -1.03 -212.12% | -1.06 | 0.03 | 2.99% |
| Q2 2023 Q2Q % growth | -0.60 18.92% | -0.92 | 0.32 | 34.77% |
| Q1 2023 Q2Q % growth | -0.87 -89.13% | -0.93 | 0.06 | 6.36% |
| Q4 2022 Q2Q % growth | -1.36 -196.45% | -0.94 | -0.42 | -44.37% |
| Q3 2022 Q2Q % growth | -0.33 43.10% | -0.76 | 0.43 | 56.43% |
| Q2 2022 Q2Q % growth | -0.74 -29.82% | -0.64 | -0.10 | -16.37% |
| Q1 2022 Q2Q % growth | -0.46 28.13% | -0.73 | 0.27 | 36.60% |
| Q4 2021 Q2Q % growth | 1.41 220.45% | 0.29 | 1.12 | 391.36% |
| Q3 2021 Q2Q % growth | -0.58 -163.64% | -0.54 | -0.04 | -8.24% |
| Q2 2021 Q2Q % growth | -0.57 -147.83% | -0.61 | 0.04 | 6.57% |
| Q1 2021 Q2Q % growth | -0.64 -82.86% | -0.54 | -0.10 | -19.44% |
| Q4 2020 Q2Q % growth | 0.44 -68.79% | 0.29 | 0.15 | 52.87% |
| Q3 2020 Q2Q % growth | -0.22 -222.22% | -0.10 | -0.12 | -127.88% |
| Q2 2020 Q2Q % growth | -0.23 -2,200.00% | -0.28 | 0.05 | 18.04% |
| Q1 2020 Q2Q % growth | -0.35 -156.45% | -0.13 | -0.22 | -171.77% |
| Q4 2019 Q2Q % growth | 1.41 | 0.95 | 0.46 | 48.46% |
| Q3 2019 Q2Q % growth | 0.18 | -0.33 | 0.51 | 154.66% |
| Q2 2019 Q2Q % growth | -0.01 | -0.28 | 0.27 | 96.38% |
| Q1 2019 Q2Q % growth | 0.62 | 0.60 | 0.02 | 3.43% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 134M -6.94% | 132.73M | 1.27M | 0.96% |
| Q2 2024 Q2Q % growth | 225.25M 19.81% | 153.07M | 72.18M | 47.15% |
| Q1 2024 Q2Q % growth | 119M -9.16% | 138.65M | -19.65M | -14.17% |
| Q4 2023 Q2Q % growth | 325M 113.96% | 178.25M | 146.75M | 82.33% |
| Q3 2023 Q2Q % growth | 144M -9.89% | 135.56M | 8.44M | 6.23% |
| Q2 2023 Q2Q % growth | 188M 40.51% | 141.6M | 46.4M | 32.77% |
| Q1 2023 Q2Q % growth | 131M -7.68% | 130.68M | 320K | 0.24% |
| Q4 2022 Q2Q % growth | 151.9M -65.48% | 161.82M | -9.92M | -6.13% |
| Q3 2022 Q2Q % growth | 159.8M 20.06% | 146.77M | 13.03M | 8.88% |
| Q2 2022 Q2Q % growth | 133.8M 6.36% | 143.33M | -9.53M | -6.65% |
| Q1 2022 Q2Q % growth | 141.9M 27.15% | 127.72M | 14.18M | 11.10% |
| Q4 2021 Q2Q % growth | 440M 51.57% | 264.33M | 175.67M | 66.46% |
| Q3 2021 Q2Q % growth | 133.1M -16.86% | 161.55M | -28.45M | -17.61% |
| Q2 2021 Q2Q % growth | 125.8M -13.54% | 139.04M | -13.24M | -9.52% |
| Q1 2021 Q2Q % growth | 111.6M -16.34% | 131.16M | -19.56M | -14.91% |
| Q4 2020 Q2Q % growth | 290.3M -41.20% | 279.97M | 10.33M | 3.69% |
| Q3 2020 Q2Q % growth | 160.1M -4.65% | 185.78M | -25.68M | -13.82% |
| Q2 2020 Q2Q % growth | 145.5M -11.17% | 151.85M | -6.35M | -4.18% |
| Q1 2020 Q2Q % growth | 133.4M -55.11% | 164.35M | -30.95M | -18.83% |
| Q4 2019 Q2Q % growth | 493.7M | 417.47M | 76.23M | 18.26% |
| Q3 2019 Q2Q % growth | 167.9M | 156.87M | 11.03M | 7.03% |
| Q2 2019 Q2Q % growth | 163.8M | 154.04M | 9.76M | 6.34% |
| Q1 2019 Q2Q % growth | 297.2M | 290.94M | 6.26M | 2.15% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -5.5% | -15.5% | -1.67% | 6.02% |
| Revenue | -3.5% | -20.96% | -0.59% | -0.86% |